Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.38 in the prior trading day, Molecular Templates Inc (NASDAQ: MTEM) closed at $0.34, down -11.76%. In other words, the price has decreased by -$11.76 from its previous closing price. On the day, 7.7 million shares were traded. MTEM stock price reached its highest trading level at $0.439 during the session, while it also had its lowest trading level at $0.335.
Ratios:
Our goal is to gain a better understanding of MTEM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.56 and its Current Ratio is at 1.56. In the meantime, Its Debt-to-Equity ratio is 1.55 whereas as Long-Term Debt/Eq ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on April 21, 2021, initiated with a Buy rating and assigned the stock a target price of $12.
On February 01, 2021, UBS started tracking the stock assigning a Neutral rating and target price of $13.
On September 08, 2020, Jefferies started tracking the stock assigning a Buy rating and target price of $21.Jefferies initiated its Buy rating on September 08, 2020, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 14 ’24 when BIOTECH TARGET N V sold 1,279,820 shares for $0.66 per share. The transaction valued at 845,833 led to the insider holds 0 shares of the business.
BIOTECH TARGET N V bought 250,000 shares of MTEM for $587,500 on Apr 02 ’24. The 10% Owner now owns 1,279,820 shares after completing the transaction at $2.35 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MTEM now has a Market Capitalization of 2207575 and an Enterprise Value of 3577575. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.08 while its Price-to-Book (P/B) ratio in mrq is 0.31. Its current Enterprise Value per Revenue stands at 0.14 whereas that against EBITDA is -0.258.
Stock Price History:
Over the past 52 weeks, MTEM has reached a high of $5.37, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -60.13%, while the 200-Day Moving Average is calculated to be -78.88%.
Shares Statistics:
The stock has traded on average 9.84M shares per day over the past 3-months and 37440420 shares per day over the last 10 days, according to various share statistics. A total of 6.58M shares are outstanding, with a floating share count of 5.44M. Insiders hold about 17.39% of the company’s shares, while institutions hold 41.02% stake in the company. Shares short for MTEM as of 1730332800 were 270132 with a Short Ratio of 0.03, compared to 1727654400 on 141846. Therefore, it implies a Short% of Shares Outstanding of 270132 and a Short% of Float of 5.8500000000000005.
